HK1143734A1 - Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent - Google Patents

Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent

Info

Publication number
HK1143734A1
HK1143734A1 HK10110083.5A HK10110083A HK1143734A1 HK 1143734 A1 HK1143734 A1 HK 1143734A1 HK 10110083 A HK10110083 A HK 10110083A HK 1143734 A1 HK1143734 A1 HK 1143734A1
Authority
HK
Hong Kong
Prior art keywords
agent
peripheral nerve
prophylactic
nerve disorder
alleviating
Prior art date
Application number
HK10110083.5A
Other languages
English (en)
Inventor
Ryozo Oishi
Yoshinori Itoh
Nobuaki Egashira
Original Assignee
Univ Kyushu Nat Univ Corp
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyushu Nat Univ Corp, Nippon Zoki Pharmaceutical Co filed Critical Univ Kyushu Nat Univ Corp
Publication of HK1143734A1 publication Critical patent/HK1143734A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
HK10110083.5A 2007-08-31 2010-10-27 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent HK1143734A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007225420 2007-08-31
JP2008032626 2008-02-14
PCT/JP2008/065399 WO2009028605A1 (ja) 2007-08-31 2008-08-28 抗がん剤による末梢神経障害の予防又は軽減剤

Publications (1)

Publication Number Publication Date
HK1143734A1 true HK1143734A1 (en) 2011-01-14

Family

ID=40387319

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10110083.5A HK1143734A1 (en) 2007-08-31 2010-10-27 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent

Country Status (11)

Country Link
US (1) US8613962B2 (de)
EP (1) EP2191836B1 (de)
JP (1) JPWO2009028605A1 (de)
KR (1) KR20100057535A (de)
CN (1) CN101790377A (de)
AU (1) AU2008292407B2 (de)
CA (1) CA2698129A1 (de)
ES (1) ES2385069T3 (de)
HK (1) HK1143734A1 (de)
TW (1) TW200911277A (de)
WO (1) WO2009028605A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2957077B1 (fr) 2010-03-02 2012-04-13 Univ Dauvergne Clermont I Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
EP2587265B1 (de) 2010-06-25 2016-05-04 Nippon Zoki Pharmaceutical Co., Ltd. Verfahren zur bestimmung oder auswertung einer testsubstanz
KR101894754B1 (ko) 2010-10-14 2018-09-04 니폰 조키 세야쿠 가부시키가이샤 연골세포의 콜라겐 및 프로테오글리칸의 합성 촉진 방법
AU2012211854A1 (en) * 2011-01-31 2013-08-08 Nagoya Industrial Science Research Institute Prophylactic or therapeutic drug for peripheral neuropathy caused by anticancer agent
JP5275502B1 (ja) * 2012-10-10 2013-08-28 日本臓器製薬株式会社 抽出物及び製剤
US9884077B2 (en) 2013-04-30 2018-02-06 Nippon Zoki Pharmaceutical Co., Ltd. Extract and preparation containing said extract
KR101732483B1 (ko) 2016-07-06 2017-05-24 한국 한의학 연구원 연교 추출물을 유효성분으로 함유하는 말초신경병증 예방, 개선 또는 치료용 조성물
JP6325036B2 (ja) * 2016-08-19 2018-05-16 株式会社明治 抗がん剤に起因する末梢神経障害を改善するための組成物
US11207354B2 (en) 2016-09-23 2021-12-28 Osaka University Schwann cell differentiation promoting agent and a peripheral nerve regeneration promoting agent
BR112021001716A2 (pt) * 2018-09-28 2021-04-27 Asahi Kasei Pharma Corporation medicamento para aliviar enfermidades e/ou suprimir o início de uma neuropatia periférica

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53101515A (en) 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS5587724A (en) 1978-12-27 1980-07-02 Nippon Zoki Pharmaceut Co Ltd Selective immune enhancer
JPH0825885B2 (ja) 1988-04-15 1996-03-13 日本臓器製薬株式会社 特発性血小板減少性紫斑病治療剤
JP2539665B2 (ja) 1988-06-20 1996-10-02 日本臓器製薬株式会社 神経疾患治療剤
JP2539669B2 (ja) 1988-07-15 1996-10-02 日本臓器製薬株式会社 糖尿病性神経障害治療剤
JP2594222B2 (ja) 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ
JP3852786B2 (ja) * 1995-04-25 2006-12-06 日本臓器製薬株式会社 骨萎縮改善剤
JP2922828B2 (ja) * 1995-08-10 1999-07-26 朝日電装株式会社 イグニッションスイッチ
JP4033936B2 (ja) 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JPH1180005A (ja) 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
JPH11139977A (ja) 1997-11-07 1999-05-25 Nippon Zoki Pharmaceut Co Ltd Ｎｅｆ作用抑制剤
JP2000016942A (ja) 1998-04-27 2000-01-18 Nippon Zoki Pharmaceut Co Ltd 虚血性疾患治療剤
US20030199535A1 (en) 1998-07-30 2003-10-23 Claudio Cavazza Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
EP1100589B1 (de) 1998-07-30 2005-01-19 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Verwendung von propionyl-l-carnitin und acetyl-l-carnitin zur herstellung von arzneimittel mit antikrebs wirkung
JP2000336034A (ja) 1999-03-19 2000-12-05 Nippon Zoki Pharmaceut Co Ltd ケモカイン産生促進剤
US8071492B2 (en) * 2001-08-20 2011-12-06 Pbi Performance Products, Inc. Textile fabric for the outer shell of a firefighter's garment
US8710095B2 (en) * 2002-04-30 2014-04-29 Bionumerik Pharmaceuticals, Inc. Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
US7148012B2 (en) 2002-10-31 2006-12-12 Nippon Zoki Pharmaceutical Co., Ltd. Therapeutic agent for fibromyalgia
JP2004300146A (ja) 2003-03-17 2004-10-28 Nippon Zoki Pharmaceut Co Ltd 感染防御剤

Also Published As

Publication number Publication date
CN101790377A (zh) 2010-07-28
AU2008292407A1 (en) 2009-03-05
TW200911277A (en) 2009-03-16
AU2008292407B2 (en) 2013-12-12
JPWO2009028605A1 (ja) 2010-12-02
WO2009028605A1 (ja) 2009-03-05
US8613962B2 (en) 2013-12-24
EP2191836A4 (de) 2011-03-30
KR20100057535A (ko) 2010-05-31
EP2191836A1 (de) 2010-06-02
US20110111051A1 (en) 2011-05-12
CA2698129A1 (en) 2009-03-05
ES2385069T3 (es) 2012-07-17
EP2191836B1 (de) 2012-05-23

Similar Documents

Publication Publication Date Title
HK1143734A1 (en) Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent
MX354686B (es) Forma de dosificacion farmaceutica que comprende 6'-fluoro-(n-metil- o n,n-dimetil-)-4-fenil-4'.9'-dihidro-3'h-espi ro[ciclohexan-1,1'-pirano[3,4,b]indol]-4-amina para el tratamiento de dolor neuropatico.
MD4736C1 (ro) Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia
UA99150C2 (ru) Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
RS54438B1 (en) PHARMACEUTICAL DOSAGE FORM CONTAINING 6`-FLUORO- (N-METHYL-OR N, N-DIMETHYL) - 4-PHENYL-4`, 9`-DIHYDRO-3`H-SPIRO [CYCLOHEXANE-1,1`-PIRANO [3,4, B] INDOL] -4-AMINE
MX345953B (es) Usos de inmunoconjugados dirigidos a cd138.
WO2011027222A3 (en) Immunogenic compositions including tlr activity modulators
GT200500137A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis.
WO2009152189A8 (en) Low dose topiramate/phentermine compostion and methods of use thereof
WO2011081493A3 (en) Pharmaceutical composition comprising metformin and rosuvastatin
WO2011106729A3 (en) Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
TW200719882A (en) Treatment of connective tissue diseases of the skin
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
TW200744617A (en) Agent increasing the production of thioredoxin
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
BR112012016783A2 (pt) "usos do composto de naltrexona ou sal farmaceuticamente aceitável da mesma a bupropiona ou sal farmaceuticamente aceitável da mesma ou de composição dos mesmos e métodos para proporcionar terapia"
EP2545929A4 (de) Mittel zur linderung oder heilung von chronischer prostatitis, interstitieller zystitis oder blasenentleerungsstörungen
PH12015502655A1 (en) Method
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
WO2012042197A3 (en) Low dose pharmaceutical composition comprising zanamivir
BR112013026933A2 (pt) uso de uma combinação de pelo menos um carotenoide
ES2325291A1 (es) "uso de un extracto de silybum marianum"
WO2011052935A3 (ko) 토복령, 여주 및 동충하초 추출물을 유효성분으로 포함하는 혈당 강하용 조성물

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190902